ArticleOncotarget2017
KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies.
Qing Wen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it